SEC Form 4 · accession 0001062993-15-003576
BIOSPECIFICS TECHNOLOGIES CORP · BSTC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul Gitman
Director
Period of report
Jun 23, 2015
Accepted (ET)
Jun 25, 2015 · 5:02 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000875622
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 par value | Jun 23, 2015 | M | 6,308 | $13.60 | A | 58,133 | D | |
| Common Stock, $0.001 par value | Jun 23, 2015 | M | 15,000 | $26.43 | A | 73,133 | D | |
| Common Stock, $0.001 par value | Jun 23, 2015 | M | 15,000 | $20.00 | A | 88,133 | D | |
| Common Stock, $0.001 par valueF2 | Jun 23, 2015 | S | 6,308 | $53.5856 | D | 81,825 | D | |
| Common Stock, $0.001 par valueF3 | Jun 23, 2015 | S | 15,000 | $51.839 | D | 66,825 | D | |
| Common Stock, $0.001 par valueF4 | Jun 23, 2015 | S | 15,000 | $50.954 | D | 51,825 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F5 | $13.60 | Jun 23, 2015 | M | 6,308 | D | — | Jun 9, 2018 | Common Stock, $0.001 par value | 6,308 | 8,692 | D |
| Stock Option (Right to Buy)F6 | $26.43 | Jun 23, 2015 | M | 15,000 | D | — | Sep 7, 2019 | Common Stock, $0.001 par value | 15,000 | 0 | D |
| Stock Option (Right to Buy)F7 | $20.00 | Jun 23, 2015 | M | 15,000 | D | — | Sep 7, 2018 | Common Stock, $0.001 par value | 15,000 | 0 | D |
Explanation of responses
- F1The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 8, 2015.
- F2The selling price of $53.5856 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $53.00 to $56.04. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F3The selling price of $51.8390 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $51.00 to $56.04. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F4The selling price of $50.9540 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $49.00 to $56.04. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F5The option was granted on June 10, 2008 and it was to vest monthly with respect to 1/12 of the total number of shares until all shares underlying the option have vested. All shares underlying the option have vested.
- F6The option was granted on September 8, 2009 and it was to vest monthly with respect to 1/12 of the total number of shares until all shares underlying the option have vested. All shares underlying the option have vested.
- F7The option was granted on September 8, 2008 and it was to vest monthly with respect to 1/12 of the total number of shares until all shares underlying the option have vested. All shares underlying the option have vested.